Related references
Note: Only part of the references are listed.Obesity, Inflammation, and Cancer
Tuo Deng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
C. S. Filgueira et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat
Jean Z. Lin et al.
CELL REPORTS (2015)
The thyroid hormone receptor β-selective agonist GC-1 does not affect tolerance to exercise in hypothyroid rats
Alexandre Goncalves et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2015)
The importance of weight management in type 2 diabetes mellitus
J. P. H. Wilding
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Brown fat and vascular heat dissipation The new cautionary tail
Amy Warner et al.
ADIPOCYTE (2014)
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health
Juliana Sih et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Leveraging nanochannels for universal, zero-order drug delivery in vivo
Silvia Ferrati et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Obesity and Body Composition for Transplant Wait-List Candidacy-Challenging or Maintaining the BMI Limits?
Kirsten L. Johansen
JOURNAL OF RENAL NUTRITION (2013)
Weight Recidivism Post-Bariatric Surgery: A Systematic Review
Shahzeer Karmali et al.
OBESITY SURGERY (2013)
Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient-2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery
Jeffrey I. Mechanick et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2013)
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
Vanessa Xanthakis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Adherence to Therapies in Patients with Type 2 Diabetes
Luis-Emilio Garcia-Perez et al.
DIABETES THERAPY (2013)
THYROID HORMONE ANALOGUES FOR THE TREATMENT OF METABOLIC DISORDERS: NEW POTENTIAL FOR UNMET CLINICAL NEEDS?
Timothy J. Shoemaker et al.
ENDOCRINE PRACTICE (2012)
The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease
D. A. Kanhai et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia
Amit A. Joharapurkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Visceral adiposity, insulin resistance and cancer risk
Claire L. Donohoe et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
Sobetirome: a case history of bench-to-clinic drug discovery and development
Thomas S. Scanlan
HEART FAILURE REVIEWS (2010)
T3 and the thyroid hormone β-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues
P. Venditti et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2009)
Reference values of clinical chemistry and hematology parameters in rhesus monkeys (Macaca mulatta)
Younan Chen et al.
XENOTRANSPLANTATION (2009)
Islet architecture A comparative study
Abraham Kim et al.
ISLETS (2009)
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Old world nonhuman primate models of type 2 diabetes mellitus
Janice D. Wagner et al.
ILAR JOURNAL (2006)
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates:: Selective actions relative to 3,5,3′-triiodo-L-thyronine
GJ Grover et al.
ENDOCRINOLOGY (2004)
Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight
JD Baxter et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Selective thyroid hormone receptor-β activation:: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability
GJ Grover et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Spared bone mass in rats treated with thyroid hormone receptor TR beta-selective compound GC-1
FRS Freitas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Relationship between regional fat distribution and insulin resistance
E Bonora
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
